2-75647146-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014763.4(MRPL19):āc.148G>Cā(p.Glu50Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000342 in 1,579,284 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014763.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRPL19 | NM_014763.4 | c.148G>C | p.Glu50Gln | missense_variant | 2/6 | ENST00000393909.7 | NP_055578.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRPL19 | ENST00000393909.7 | c.148G>C | p.Glu50Gln | missense_variant | 2/6 | 1 | NM_014763.4 | ENSP00000377486 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152212Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000215 AC: 4AN: 186228Hom.: 0 AF XY: 0.0000297 AC XY: 3AN XY: 100912
GnomAD4 exome AF: 0.0000133 AC: 19AN: 1426954Hom.: 0 Cov.: 31 AF XY: 0.0000113 AC XY: 8AN XY: 706686
GnomAD4 genome AF: 0.000230 AC: 35AN: 152330Hom.: 0 Cov.: 33 AF XY: 0.000282 AC XY: 21AN XY: 74492
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.148G>C (p.E50Q) alteration is located in exon 2 (coding exon 2) of the MRPL19 gene. This alteration results from a G to C substitution at nucleotide position 148, causing the glutamic acid (E) at amino acid position 50 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at